摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-甲基吡啶-2-基)苯甲醛 | 289469-97-2

中文名称
4-(4-甲基吡啶-2-基)苯甲醛
中文别名
2-[4-(吗啉-4-羰基)喹啉-2-基]丙二腈
英文名称
4-(4-methylpyridin-2-yl)benzaldehyde
英文别名
——
4-(4-甲基吡啶-2-基)苯甲醛化学式
CAS
289469-97-2
化学式
C13H11NO
mdl
——
分子量
197.236
InChiKey
GHBLNQSCMJBLNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    30
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:f2b3f17569d7d571442d743fd0918431
查看

反应信息

  • 作为反应物:
    描述:
    4-(4-甲基吡啶-2-基)苯甲醛盐酸羟胺 作用下, 以 乙醇 为溶剂, 生成 4-(4-methylpyridin-2-yl)benzaldehyde oxime
    参考文献:
    名称:
    Pyridine compounds and their pharmaceutical use
    摘要:
    根据所附的规格说明书,本发明的化合物(I)和药用可接受的盐具有强烈的抑制一氧化氮(NO)生成的活性,并且可用于预防或治疗由NOS(一氧化氮合酶)介导的疾病,例如成人的呼吸窘迫综合征、心肌炎、滑膜炎、败血症休克、胰岛素依赖型糖尿病、溃疡性结肠炎、脑梗塞、类风湿性关节炎、骨关节炎、骨质疏松症、系统性红斑狼疮、器官移植排斥反应、哮喘、疼痛、溃疡等人类和动物的疾病。
    公开号:
    US06521643B1
  • 作为产物:
    描述:
    2-氯-4-甲基吡啶4-羟甲基苯硼酸 在 C46H49BrClFeN3Pd 、 copper diacetate 、 caesium carbonate 作用下, 以 1,4-二氧六环 为溶剂, 反应 24.0h, 以82%的产率得到4-(4-甲基吡啶-2-基)苯甲醛
    参考文献:
    名称:
    Synthesis, crystal structures and catalytic activity of three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with N -heterocyclic carbenes (NHCs) and triphenylphosphine
    摘要:
    Three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with NHCs and PPh3 1-3 have been synthesized and characterized by elemental analysis, IR, NMR and single-crystal X-ray diffraction. Their application to Suzuki coupling of phenylboronic acid containing hydroxymethyl was also investigated. An efficient 3/Cu cocatalyzed oxidation/Suzuki coupling of aryl chlorides with phenylboronic acids containing hydroxymethyl in air has been developed. (C) 2014 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ica.2014.07.037
点击查看最新优质反应信息

文献信息

  • PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE
    申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
    公开号:EP1157022A1
    公开(公告)日:2001-11-28
  • US6521643B1
    申请人:——
    公开号:US6521643B1
    公开(公告)日:2003-02-18
  • [EN] PYRIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USE<br/>[FR] COMPOSES PYRIDINE ET LEUR UTILISATION PHARMACEUTIQUE
    申请人:FUJISAWA PHARMACEUTICAL CO
    公开号:WO2000049015A1
    公开(公告)日:2000-08-24
    A compound of formula (I) wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NOS(nitric oxide synthase)-mediated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, insulin-dependent diabetes mellitus, ulcerative colitis, cerebral infarction, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, rejection by organ transplantation, asthma, pain, ulcer, and the like in human being and animals.
  • Pyridine compounds and their pharmaceutical use
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US06521643B1
    公开(公告)日:2003-02-18
    A compound of formula (I) wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NOS(nitric oxide synthasey)-mediated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, insulin-ependent diabetes mellitus, ulcerative colitis, cerebral infarction, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, rejection by organ transplantation, asthma, pain, ulcer, and the like in human being and animals.
    根据所附的规格说明书,本发明的化合物(I)和药用可接受的盐具有强烈的抑制一氧化氮(NO)生成的活性,并且可用于预防或治疗由NOS(一氧化氮合酶)介导的疾病,例如成人的呼吸窘迫综合征、心肌炎、滑膜炎、败血症休克、胰岛素依赖型糖尿病、溃疡性结肠炎、脑梗塞、类风湿性关节炎、骨关节炎、骨质疏松症、系统性红斑狼疮、器官移植排斥反应、哮喘、疼痛、溃疡等人类和动物的疾病。
  • Synthesis, crystal structures and catalytic activity of three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with N -heterocyclic carbenes (NHCs) and triphenylphosphine
    作者:Chen Xu、Hong-Mei Li、Zhi-Qiang Wang、Wei-Jun Fu
    DOI:10.1016/j.ica.2014.07.037
    日期:2014.11
    Three cyclopalladated 6-bromo-2-ferrocenylquinoline complexes with NHCs and PPh3 1-3 have been synthesized and characterized by elemental analysis, IR, NMR and single-crystal X-ray diffraction. Their application to Suzuki coupling of phenylboronic acid containing hydroxymethyl was also investigated. An efficient 3/Cu cocatalyzed oxidation/Suzuki coupling of aryl chlorides with phenylboronic acids containing hydroxymethyl in air has been developed. (C) 2014 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-